{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:50:50Z","timestamp":1770040250665,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.biologicals.2021.06.002","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T07:43:45Z","timestamp":1624261425000},"page":"10-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Immunization effect of lipopolysaccharide antigen in conjugation with PLGA nanoparticles as a nanovaccine against Brucella melitensis infection"],"prefix":"10.1016","volume":"72","author":[{"given":"Masoud","family":"Maleki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Salouti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2021.06.002_bib1","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1021\/acs.accounts.7b00445","article-title":"Brucellosis: improved diagnostics and vaccine insights from synthetic glycans","volume":"50","author":"Bundle","year":"2017","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.biologicals.2021.06.002_bib2","first-page":"1500846","article-title":"Comparisons of brucellosis between human and veterinary medicine","volume":"8","author":"Hull","year":"2018","journal-title":"Infect Ecol Epidemiol"},{"key":"10.1016\/j.biologicals.2021.06.002_bib3","first-page":"1","article-title":"Review of bacterial and viral zoonotic infections transmitted by dogs","volume":"8","author":"Ghasemzadeh","year":"2015","journal-title":"Journal of medicine and life"},{"key":"10.1016\/j.biologicals.2021.06.002_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13567-015-0199-7","article-title":"Recent advances in Brucella abortus vaccines","volume":"46","author":"Dorneles","year":"2015","journal-title":"Vet Res"},{"key":"10.1016\/j.biologicals.2021.06.002_bib5","first-page":"472","article-title":"Safety and immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle","volume":"58","author":"Palmer","year":"1997","journal-title":"AJVR (Am J Vet Res)"},{"key":"10.1016\/j.biologicals.2021.06.002_bib6","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1016\/j.vaccine.2016.08.059","article-title":"Identification of Brucella melitensis Rev. 1 vaccine-strain genetic markers: towards understanding the molecular mechanism behind virulence attenuation","volume":"34","author":"Issa","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2021.06.002_bib7","series-title":"Brucella lipopolysaccharide and pathogenicity: the core of the matter","author":"Smith","year":"2018"},{"key":"10.1016\/j.biologicals.2021.06.002_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40064-015-0972-0","article-title":"The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm","volume":"4","author":"Ghimire","year":"2015","journal-title":"SpringerPlus"},{"key":"10.1016\/j.biologicals.2021.06.002_bib9","doi-asserted-by":"crossref","first-page":"690","DOI":"10.2105\/AJPH.32.7.690","article-title":"Diphtheria immunization with fluid toxoid and alum-precipitated toxoid","volume":"32","author":"Volk","year":"1942","journal-title":"Am J Public Health Nation's Health"},{"key":"10.1016\/j.biologicals.2021.06.002_bib10","first-page":"1003","article-title":"Potentiation of human papilloma vaccine candidate using naloxone\/alum mixture as an adjuvant: increasing immunogenicity of HPV-16E7d vaccine","volume":"19","author":"Yasaghi","year":"2016","journal-title":"Iranian journal of basic medical sciences"},{"key":"10.1016\/j.biologicals.2021.06.002_bib11","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0264-410X(99)00566-6","article-title":"A hepatitis B vaccine formulated with a novel adjuvant system","volume":"18","author":"Ambrosch","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2021.06.002_bib12","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","article-title":"PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity","volume":"12","author":"Silva","year":"2016","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biologicals.2021.06.002_bib13","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.2147\/IJN.S141069","article-title":"Vaccination with poly (D, L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNF\u03b1-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis","volume":"12","author":"Margaroni","year":"2017","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.biologicals.2021.06.002_bib14","first-page":"813","article-title":"Development of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague","volume":"9","author":"Huang","year":"2014","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.biologicals.2021.06.002_bib15","doi-asserted-by":"crossref","DOI":"10.1088\/2057-1976\/aabfac","article-title":"Synthesis and immunological evaluation of a nanovaccine based on PLGA nanoparticles and alginate antigen against infections caused by Pseudomonas aeruginosa","volume":"4","author":"Alikhani","year":"2018","journal-title":"Biomedical Physics & Engineering Express"},{"key":"10.1016\/j.biologicals.2021.06.002_bib16","first-page":"2085","article-title":"Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine","volume":"8","author":"Fairley","year":"2013","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.biologicals.2021.06.002_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194620","article-title":"PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection","volume":"13","author":"Ashhurst","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.biologicals.2021.06.002_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1297-9716-43-20","article-title":"Protective effect of recombinant staphylococcal enterotoxin A entrapped in polylactic-co-glycolic acid microspheres against Staphylococcus aureus infection","volume":"43","author":"Chen","year":"2012","journal-title":"Vet Res"},{"key":"10.1016\/j.biologicals.2021.06.002_bib19","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1080\/21691401.2019.1687490","article-title":"Preparation of a nanovaccine against Brucella melitensis M16 based on PLGA nanoparticles and oligopolysaccharide antigen","volume":"47","author":"Maleki","year":"2019","journal-title":"Artificial cells, nanomedicine, and biotechnology"},{"key":"10.1016\/j.biologicals.2021.06.002_bib20","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant","volume":"65","author":"Casella","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.biologicals.2021.06.002_bib21","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1128\/iai.57.9.2820-2828.1989","article-title":"Fine structure of A and M antigens from Brucella biovars","volume":"57","author":"Meikle","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2021.06.002_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1128\/iai.59.1.45-50.1991","article-title":"Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine","volume":"59","author":"Cryz","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2021.06.002_bib23","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/IAI.67.11.5806-5810.1999","article-title":"Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2-to 4-year-old children in Vietnam","volume":"67","author":"Kossaczka","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2021.06.002_bib24","first-page":"3","article-title":"Extraction, purification and characterization of lipopolysaccharide from Escherichia coli and Salmonella typhi","volume":"3","author":"Rezania","year":"2011","journal-title":"Avicenna J Med Biotechnol (AJMB)"},{"key":"10.1016\/j.biologicals.2021.06.002_bib25","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1016\/S0021-9258(19)68962-3","article-title":"Preparation and characterization of detoxified lipopolysaccharide-protein conjugates","volume":"256","author":"Seid","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biologicals.2021.06.002_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/apm.12337","article-title":"Immunological evaluation of an alginate\u2010based conjugate as a vaccine candidate against Pseudomonas aeruginosa","volume":"123","author":"Farjah","year":"2015","journal-title":"Apmis"},{"key":"10.1016\/j.biologicals.2021.06.002_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jconrel.2004.07.025","article-title":"WGA-grafted PLGA-nanospheres: preparation and association with Caco-2 single cells","volume":"99","author":"Weissenb\u00f6ck","year":"2004","journal-title":"J Contr Release"},{"key":"10.1016\/j.biologicals.2021.06.002_bib28","first-page":"19670","article-title":"Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer","volume":"8","author":"Sun","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.biologicals.2021.06.002_bib29","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.3109\/03639045.2015.1019355","article-title":"Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity","volume":"41","author":"Singh","year":"2015","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.biologicals.2021.06.002_bib30","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1128\/IAI.74.2.975-983.2006","article-title":"A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection","volume":"74","author":"Zaidi","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2021.06.002_bib31","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1099\/jmm.0.46696-0","article-title":"Synthesis and characterization of Pseudomonas aeruginosa alginate\u2013tetanus toxoid conjugate","volume":"55","author":"Kashef","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.biologicals.2021.06.002_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1590\/S0100-879X2001000200008","article-title":"Stabilization of serum antibody responses triggered by initial mucosal contact with the antigen independently of oral tolerance induction","volume":"34","author":"Verdolin","year":"2001","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.biologicals.2021.06.002_bib33","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.inf.0000129688.50588.ac","article-title":"Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection","volume":"23","author":"Lang","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.biologicals.2021.06.002_bib34","doi-asserted-by":"crossref","first-page":"110021","DOI":"10.1016\/j.eurpolymj.2020.110021","article-title":"Immunological effects of two new nanovaccines against Brucella based on OPS and LPS antigens conjugated with PLGA nanoparticles","author":"Afshari","year":"2020","journal-title":"Eur Polym J"},{"key":"10.1016\/j.biologicals.2021.06.002_bib35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0168-1605(03)00189-2","article-title":"Opsonophagocytic assay as a potentially useful tool for assessing safety of enterococcal preparations","volume":"88","author":"Hufnagel","year":"2003","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.biologicals.2021.06.002_bib36","first-page":"287","article-title":"Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae","volume":"12","author":"Hu","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.biologicals.2021.06.002_bib37","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1128\/IAI.69.8.4816-4822.2001","article-title":"Protection of BALB\/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant","volume":"69","author":"Al-Mariri","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2021.06.002_bib38","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.vaccine.2009.12.012","article-title":"Protection of BALB\/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherichia coli expression Brucella P39 protein","volume":"28","author":"Al-Mariri","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2021.06.002_bib39","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2217\/nnm.14.187","article-title":"Recent advances in peptide-based subunit nanovaccines","volume":"9","author":"Skwarczynski","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biologicals.2021.06.002_bib40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2567.2008.02832.x","article-title":"The modulatory effects of lipopolysaccharide\u2010stimulated B cells on differential T\u2010cell polarization","volume":"125","author":"Xu","year":"2008","journal-title":"Immunology"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105621000579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105621000579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:14:36Z","timestamp":1760922876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105621000579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":40,"alternative-id":["S1045105621000579"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2021.06.002","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization effect of lipopolysaccharide antigen in conjugation with PLGA nanoparticles as a nanovaccine against Brucella melitensis infection","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2021.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}